Cardiac Progenitor Cells and the Interplay with Their Microenvironment

Stem Cells International

Volumn 2017, Issue , 2017, Pages

  Mauretti, Arianna ^a   Spaans, Sergio ^a   Bax, Noortje A M ^a   Sahlgren, Cecilia ^a,b   Bouten, Carlijn V C ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; COLLAGEN TYPE 1; CYCLINE; MYOSIN LIGHT CHAIN 2; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL ENGINEERING; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELL REGENERATION; CELL SELF-RENEWAL; CELL STRUCTURE; CELLULAR STRESS RESPONSE; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EPICARDIUM DERIVED CELL; EXTRACELLULAR MATRIX; FIBROBLAST; FOCAL ADHESION; HEART INFARCTION; IMMUNOCOMPETENT CELL; MACROPHAGE; MAST CELL; MECHANICAL STIMULATION; NATURAL KILLER CELL; NOTCH SIGNALING; OXYGEN TENSION; PLURIPOTENT STEM CELL; REVIEW; SIDE POPULATION CELL; STEM CELL NICHE; STROMA CELL; TELOCYTE;

EID: 85030769268     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2017/7471582     Document Type: Review

References (233)

1. C. M. Ripplinger, S. F. Noujaim, and D. Linz, "The nervous heart," Progress in Biophysics and Molecular Biology, vol. 120, no. 1-3, pp. 199-209, 2016.
2. M. Ieda, "Heart development, diseases, and regeneration-new approaches from innervation, fibroblasts, and reprogramming," Circulation Journal, vol. 80, no. 10, pp. 2081-2088, 2016.
3. N. Smart, "Prospects for improving neovascularization of the ischemic heart: lessons from development," Microcirculation, vol. 24, no. 1, 2017.
4. E. Graham and O. Bergmann, "Dating the heart: exploring cardiomyocyte renewal in humans," Physiology (Bethesda, Maryland), vol. 32, no. 1, pp. 33-41, 2017.
5. O. Bergmann, S. Zdunek, A. Felker et al., "Dynamics of cell generation and turnover in the human heart," Cell, vol. 161, no. 7, pp. 1566-1575, 2015.
6. K. Urbanek, D. Torella, F. Sheikh et al., "Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8692-8697, 2005.
7. J. Bloomekatz, M. Galvez-Santisteban, and N. C. Chi, "Myocardial plasticity: cardiac development, regeneration and disease," Current Opinion in Genetics & Development, vol. 40, pp. 120-130, 2016.
8. J. H. van Berlo and J. D. Molkentin, "An emerging consensus on cardiac regeneration," Nature Medicine, vol. 20, no. 12, pp. 1386-1393, 2014.
9. S. X. Liang and W. D. Phillips, "Migration of resident cardiac stem cells in myocardial infarction," The Anatomical Record, vol. 296, no. 2, pp. 184-191, 2013.
10. H. Oh, S. B. Bradfute, T. D. Gallardo et al., "Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 21, pp. 12313-12318, 2003.
11. T. Y. L. Le and J. J. H. Chong, "Cardiac progenitor cells for heart repair," Cell Death Discovery, vol. 2, article 16052, 2016.
12. K. Urbanek, F. Quaini, G. Tasca et al., "Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10440-10445, 2003.
13. K. Matsuura, T. Nagai, N. Nishigaki et al., "Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes," The Journal of Biological Chemistry, vol. 279, no. 12, pp. 11384-11391, 2004.
14. O. Pfister, F. Mouquet, M. Jain et al., "CD31-but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation," Circulation Research, vol. 97, no. 1, pp. 52-61, 2005.
15. N. A. M. Bax, M. H. van Marion, B. Shah, M.-J. Goumans, C. V. C. Bouten, and D. W. J. van der Schaft, "Matrix production and remodeling capacity of cardiomyocyte progenitor cells during in vitro differentiation," Journal of Molecular and Cellular Cardiology, vol. 53, no. 4, pp. 497-508, 2012.
16. A. J. Boyle, S. P. Schulman, J. M. Hare, and P. Oettgen, "Is stem cell therapy ready for patients? Stem cell therapy for cardiac repair. Ready for the next step," Circulation, vol. 114, no. 4, pp. 339-352, 2006.
17. P. P. Zwetsloot, A. M. D. Végh, S. J. Jansen of Lorkeers et al., "Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies," Circulation Research, vol. 118, no. 8, pp. 1223-1232, 2016.
18. P. Menasche, "Cardiac cell therapy: lessons from clinical trials," Journal of Molecular and Cellular Cardiology, vol. 50, no. 2, pp. 258-265, 2011.
19. K. Malliaras and E. Marban, "Cardiac cell therapy: where we've been, where we are, and where we should be headed," British Medical Bulletin, vol. 98, pp. 161-185, 2011.
20. D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans, "Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window," Cardiovascular Research, vol. 69, no. 3, pp. 604-613, 2006.
21. J. C. Deddens, A. H. Sadeghi, J. Hjortnaes et al., "Modeling the human scarred heart in vitro: toward new tissue engineered models," Advanced Healthcare Materials, vol. 6, no. 3, 2017.
22. M. Dobaczewski, C. Gonzalez-Quesada, and N. G. Frangogiannis, "The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction," Journal of Molecular and Cellular Cardiology, vol. 48, no. 3, pp. 504-511, 2010.
23. D. L. Jones and A. J. Wagers, "No place like home: anatomy and function of the stem cell niche," Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 11-21, 2008.
24. K. A. Moore and I. R. Lemischka, "Stem cells and their niches," Science, vol. 311, no. 5769, pp. 1880-1885, 2006.
25. R. Schofield, "The relationship between the spleen colonyforming cell and the haemopoietic stem cell," Blood Cells, vol. 4, no. 1-2, pp. 7-25, 1978.
26. S. J. Morrison and A. C. Spradling, "Stem cells and niches: mechanisms that promote stem cell maintenance throughout life," Cell, vol. 132, no. 4, pp. 598-611, 2008.
27. K. Urbanek, D. Cesselli, M. Rota et al., "Stem cell niches in the adult mouse heart," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9226-9231, 2006.
28. A. Leri, M. Rota, T. Hosoda, P. Goichberg, and P. Anversa, "Cardiac stem cell niches," Stem Cell Research, vol. 13, no. 3, Part B, pp. 631-646, 2014.
29. C. M. Martin, A. P. Meeson, S. M. Robertson et al., "Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart," Developmental Biology, vol. 265, no. 1, pp. 262-275, 2004.
30. K. Wei, V. Serpooshan, C. Hurtado et al., "Epicardial FSTL1 reconstitution regenerates the adult mammalian heart," Nature, vol. 525, no. 7570, pp. 479-485, 2015.
31. S. X. Liang, T. Y. L. Tan, L. Gaudry, and B. Chong, "Differentiation and migration of Sca1+/CD31-cardiac side population cells in a murine myocardial ischemic model," International Journal of Cardiology, vol. 138, no. 1, pp. 40-49, 2010.
32. A. M. Hierlihy, P. Seale, C. G. Lobe, M. A. Rudnicki, and L. A. Megeney, "The post-natal heart contains a myocardial stem cell population," FEBS Letters, vol. 530, no. 1-3, pp. 239-243, 2002.
33. T. Oyama, T. Nagai, H. Wada et al., "Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo," The Journal of Cell Biology, vol. 176, no. 3, pp. 329-341, 2007.
34. M. Alfakir, N. Dawe, R. Eyre et al., "The temporal and spatial expression patterns of ABCG2 in the developing human heart," International Journal of Cardiology, vol. 156, no. 2, pp. 133-138, 2012.
35. J. Sandstedt, M. Jonsson, K. Vukusic et al., "SSEA-4+ CD34-cells in the adult human heart show the molecular characteristics of a novel cardiomyocyte progenitor population," Cells, Tissues, Organs, vol. 199, no. 2-3, pp. 103-116, 2014.
36. S. X. Liang, L. M. Khachigian, Z. Ahmadi, M. Yang, S. Liu, and B. H. Chong, "In vitro and in vivo proliferation, differentiation and migration of cardiac endothelial progenitor cells (SCA1+/CD31+ side-population cells)," Journal of Thrombosis and Haemostasis, vol. 9, no. 8, pp. 1628-1637, 2011.
37. K. Yamahara, S. Fukushima, S. R. Coppen et al., "Heterogeneic nature of adult cardiac side population cells," Biochemical and Biophysical Research Communications, vol. 371, no. 4, pp. 615-620, 2008.
38. M. Y. Emmert, L. S. Emmert, A. Martens et al., "Higher frequencies of BCRP+ cardiac resident cells in ischaemic human myocardium," European Heart Journal, vol. 34, no. 36, pp. 2830-2838, 2013.
39. E. B. Lushaj, L. Lozonschi, M. Barnes, E. Anstadt, and T. Kohmoto, "Mitochondrial DNA deletion mutations in adult mouse cardiac side population cells," Mutation Research, vol. 734, no. 1-2, pp. 62-68, 2012.
40. E. Belian, M. Noseda, M. S. Abreu Paiva, T. Leja, R. Sampson, and M. D. Schneider, "Forward programming of cardiac stem cells by homogeneous transduction with MYOCD plus TBX5," PLoS One, vol. 10, no. 6, article e0125384, 2015.
41. J. Yoon, S. C. Choi, C. Y. Park, W. J. Shim, and D.-S. Lim, "Cardiac side population cells exhibit endothelial differentiation potential," Experimental & Molecular Medicine, vol. 39, no. 5, pp. 653-662, 2007.
42. F. Mouquet, O. Pfister, M. Jain et al., "Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrowderived stem cells," Circulation Research, vol. 97, no. 11, pp. 1090-1092, 2005.
43. C. M. Martin, A. Ferdous, T. Gallardo et al., "Hypoxiainducible factor-2alpha transactivates Abcg2 and promotes cytoprotection in cardiac side population cells," Circulation Research, vol. 102, no. 9, pp. 1075-1081, 2008.
44. K. Meissner, B. Heydrich, G. Jedlitschky et al., "The ATPbinding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart," The Journal of Histochemistry and Cytochemistry, vol. 54, no. 2, pp. 215-221, 2006.
45. A. P. Beltrami, L. Barlucchi, D. Torella et al., "Adult cardiac stem cells are multipotent and support myocardial regeneration," Cell, vol. 114, no. 6, pp. 763-776, 2003.
46. G. M. Ellison, V. Galuppo, C. Vicinanza et al., "Cardiac stem and progenitor cell identification: different markers for the same cell?," Fronteirs in Bioscience (Scholar Edition), vol. 2, pp. 641-652, 2010.
47. C. Bearzi, M. Rota, T. Hosoda et al., "Human cardiac stem cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068-14073, 2007.
48. N. Sultana, L. Zhang, J. Yan et al., "Resident c-kit(+) cells in the heart are not cardiac stem cells," Nature Communications, vol. 6, p. 8701, 2015.
49. M. M. Zaruba, M. Soonpaa, S. Reuter, and L. J. Field, "Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts," Circulation, vol. 121, no. 18, pp. 1992-2000, 2010.
50. M. Hesse, B. K. Fleischmann, and M. I. Kotlikoff, "Concise review: the role of C-kit expressing cells in heart repair at the neonatal and adult stage," Stem Cells, vol. 32, no. 7, pp. 1701-1712, 2014.
51. C. Castaldo, F. Di Meglio, D. Nurzynska et al., "CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression," Stem Cells, vol. 26, pp. 1723-1731, 2008.
52. S. Matuszczak, J. Czapla, M. Jarosz-Biej et al., "Characteristic of c-kit+ progenitor cells in explanted human hearts," Clinical Research in Cardiology, vol. 103, no. 9, pp. 711-718, 2014.
53. Y. N. Tallini, K. S. Greene, M. Craven et al., "C-kit expression identifies cardiovascular precursors in the neonatal heart," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1808-1813, 2009.
54. M. Saravanakumar and H. Devaraj, "Distribution and homing pattern of c-kit+ Sca-1+ CXCR4+ resident cardiac stem cells in neonatal, postnatal, and adult mouse heart," Cardiovascular Pathology, vol. 22, no. 4, pp. 257-263, 2013.
55. A. Linke, P. Muller, D. Nurzynska et al., "Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 25, pp. 8966-8971, 2005.
56. G. M. Ellison, D. Torella, S. Dellegrottaglie et al., "Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart," Journal of the American College of Cardiology, vol. 58, no. 9, pp. 977-986, 2011.
57. X. Hou, N. Appleby, T. Fuentes et al., "Isolation, characterization, and spatial distribution of cardiac progenitor cells in the sheep heart," Journal of Clinical & Experimental Cardiology, vol. S6, 2012.
58. D. Dey, L. Han, M. Bauer et al., "Dissecting the molecular relationship among various cardiogenic progenitor cells," Circulation Research, vol. 112, no. 9, pp. 1253-1262, 2013.
59. P. Anversa, J. Kajstura, A. Leri, and R. Bolli, "Life and death of cardiac stem cells: a paradigm shift in cardiac biology," Circulation, vol. 113, no. 11, pp. 1451-1463, 2006.
60. M. P. Santini, E. Forte, R. P. Harvey, and J. C. Kovacic, "Developmental origin and lineage plasticity of endogenous cardiac stem cells," Development, vol. 143, pp. 1242-1258, 2016.
61. S. A. Jesty, M. A. Steffey, F. K. Lee et al., "C-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 33, pp. 13380-13385, 2012.
62. D. L. Simpson, R. Mishra, S. Sharma, S. K. Goh, S. Deshmukh, and S. Kaushal, "A strong regenerative ability of cardiac stem cells derived from neonatal hearts," Circulation, vol. 126, no. 11, Supplement 1, pp. S46-S53, 2012.
63. F. Limana, A. Zacheo, D. Mocini et al., "Identification of myocardial and vascular precursor cells in human and mouse epicardium," Circulation Research, vol. 101, no. 12, pp. 1255-1265, 2007.
64. C. Di Filippo, M. Luongo, R. Marfella et al., "Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment," Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 382, no. 3, pp. 287-291, 2010.
65. C. Di Filippo, M. Perretti, F. Rossi, F. Ferraraccio, R. Motterlini, and M. D'Amico, "Acute myocardial infarction in streptozotocin-induced hyperglycaemic rats: protection by a carbon monoxide-releasing molecule (CORM-3)," Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 385, no. 2, pp. 137-144, 2012.
66. L. Zakharova, H. Nural-Guvener, J. Nimlos, S. Popovic, and M. A. Gaballa, "Chronic heart failure is associated with transforming growth factor beta-dependent yield and functional decline in atrial explant-derived c-kit+ cells," Journal of the American Heart Association, vol. 2, no. 5, article e000317, 2013.
67. A. Itzhaki-Alfia, J. Leor, E. Raanani et al., "Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells," Circulation, vol. 120, no. 25, pp. 2559-2566, 2009.
68. M. Rota, M. E. Padin-Iruegas, Y. Misao et al., "Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function," Circulation Research, vol. 103, no. 1, pp. 107-116, 2008.
69. X.-L. Tang, G. Rokosh, S. K. Sanganalmath et al., "Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction," Circulation, vol. 121, no. 2, pp. 293-305, 2010.
70. R. Bolli, X.-L. Tang, S. K. Sanganalmath et al., "Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy," Circulation, vol. 128, no. 2, pp. 122-131, 2013.
71. R. Bolli, A. R. Chugh, D. D'Amario et al., "Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial," Lancet (London, England), vol. 378, no. 9806, pp. 1847-1857, 2011.
72. A. R. Chugh, G. M. Beache, J. H. Loughran et al., "Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance," Circulation, vol. 126, no. 11, Supplement 1, pp. S54-S64, 2012.
73. P. van Vliet, M. Roccio, A. M. Smits et al., "Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy," Netherlands Heart Journal, vol. 16, no. 5, pp. 163-169, 2008.
74. X. Wang, Q. Hu, Y. Nakamura et al., "The role of the Sca-1 +/CD31-cardiac progenitor cell population in postinfarction left ventricular remodeling," Stem Cells, vol. 24, no. 7, pp. 1779-1788, 2006.
75. M. J. Goumans, T. P. de Boer, A. M. Smits et al., "TGF-?1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro," Stem Cell Research, vol. 1, no. 2, pp. 138-149, 2008.
76. A. M. Smits, P. van Vliet, C. H. Metz et al., "Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology," Nature Protocols, vol. 4, no. 2, pp. 232-243, 2009.
77. P. van Vliet, T. P. de Boer, M. A. G. van der Heyden et al., "Hyperpolarization induces differentiation in human cardiomyocyte progenitor cells," Stem Cell Reviews, vol. 6, no. 2, pp. 178-185, 2010.
78. P. van Vliet, A. M. Smits, T. P. de Boer et al., "Foetal and adult cardiomyocyte progenitor cells have different developmental potential," Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 861-870, 2010.
79. K. Matsuura, A. Honda, T. Nagai et al., "Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice," Journal of Clinical Investigation, vol. 119, no. 8, 2009.
80. M. C. den Haan, R. W. Grauss, A. M. Smits et al., "Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts," Journal of Cellular and Molecular Medicine, vol. 16, no. 7, pp. 1508-1521, 2012.
81. J. W. Holmes, T. K. Borg, and J. W. Covell, "Structure and mechanics of healing myocardial infarcts," Annual Review of Biomedical Engineering, vol. 7, pp. 223-253, 2005.
82. H. W. Leung, A. T. Moerkamp, J. Padmanabhan, S.-W. Ng, M.-J. Goumans, and A. Choo, "mAb C19 targets a novel surface marker for the isolation of human cardiac progenitor cells from human heart tissue and differentiated hESCs," Journal of Molecular and Cellular Cardiology, vol. 82, pp. 228-237, 2015.
83. L. Barile, M. Gherghiceanu, L. M. Popescu, T. Moccetti, and G. Vassalli, "Human cardiospheres as a source of multipotent stem and progenitor cells," Stem Cells International, vol. 2013, Article ID 916837, 10 pages, 2013.
84. C. F. Leite, T. R. Almeida, C. S. Lopes, and V. J. Dias da Silva, "Multipotent stem cells of the heart-do they have therapeutic promise?," Frontiers in Physiology, vol. 6, p. 123, 2015.
85. A. Moretti, L. Caron, A. Nakano et al., "Multipotent embryonic Isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification," Cell, vol. 127, no. 6, pp. 1151-1165, 2006.
86. P. Pandur, I. O. Sirbu, S. J. Kühl, M. Philipp, and M. Kühl, "Islet1-expressing cardiac progenitor cells: a comparison across species," Development Genes and Evolution, vol. 223, no. 1-2, pp. 117-129, 2013.
87. C. L. Cai, X. Liang, Y. Shi et al., "Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart," Developmental Cell, vol. 5, no. 6, pp. 877-889, 2003.
88. R. Genead, C. Danielsson, A. B. Andersson et al., "Islet-1 cells are cardiac progenitors present during the entire lifespan: from the embryonic stage to adulthood," Stem Cells and Development, vol. 19, no. 10, pp. 1601-1615, 2010.
89. L. Bu, X. Jiang, S. Martin-Puig et al., "Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages," Nature, vol. 460, no. 7251, pp. 113-117, 2009.
90. K.-L. Laugwitz, A. Moretti, J. Lam et al., "Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages," Nature, vol. 433, no. 7026, pp. 647-653, 2005.
91. G. Amir, X. Ma, V. M. Reddy et al., "Dynamics of human myocardial progenitor cell populations in the neonatal period," The Annals of Thoracic Surgery, vol. 86, pp. 1311-1319, 2008.
92. K. L. Laugwitz, A. Moretti, L. Caron, A. Nakano, and K. R. Chien, "Islet1 cardiovascular progenitors: a single source for heart lineages?," Development, vol. 135, no. 2, pp. 193-205, 2008.
93. Y. Qyang, S. Martin-Puig, M. Chiravuri et al., "The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway," Cell Stem Cell, vol. 1, no. 2, pp. 165-179, 2007.
94. P. Khattar, F. W. Friedrich, G. Bonne et al., "Distinction between two populations of islet-1-positive cells in hearts of different murine strains," Stem Cells and Development, vol. 20, no. 6, pp. 1043-1052, 2011.
95. R. Genead, H. Fischer, A. Hussain et al., "Ischemia-reperfusion injury and pregnancy initiate time-dependent and robust signs of up-regulation of cardiac progenitor cells," PloS One, vol. 7, no. 5, article e36804, 2012.
96. E. Messina, L. De Angelis, G. Frati et al., "Isolation and expansion of adult cardiac stem cells from human and murine heart," Circulation Research, vol. 95, no. 9, pp. 911-921, 2004.
97. I. Chimenti, R. Gaetani, L. Barile et al., "Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts," in Somatic Stem Cells: Methods and Protocols, S. R. Singh, Ed., pp. 327-338, Humana Press, Totowa, NJ, USA, 2012.
98. R. R. Smith, L. Barile, H. C. Cho et al., "Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens," Circulation, vol. 115, no. 7, pp. 896-908, 2007.
99. D. R. Davis, Y. Zhang, R. R. Smith et al., "Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue," PLoS One, vol. 4, no. 9, article e7195, 2009.
100. T.-S. Li, K. Cheng, S.-T. Lee et al., "Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cellmatrix interactions, rationalizing their enhanced functional potency for myocardial repair," Stem Cells, vol. 28, no. 11, pp. 2088-2098, 2010.
101. P. V. Johnston, T. Sasano, K. Mills et al., "Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy," Circulation, vol. 120, no. 12, pp. 1075-1083, 2009.
102. S.-T. Lee, A. J. White, S. Matsushita et al., "Intramyocardial injection of autologous cardiospheres or cardiospherederived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure postmyocardial infarction," Journal of the American College of Cardiology, vol. 57, no. 4, pp. 455-465, 2011.
103. D. Shen, K. Cheng, and E. Marbán, "Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction," Journal of Cellular and Molecular Medicine, vol. 16, no. 9, pp. 2112-2116, 2012.
104. K. Cheng, K. Malliaras, R. R. Smith et al., "Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair," JACC Heart Failure, vol. 2, no. 1, pp. 49-61, 2014.
105. E. Tseliou, H. Reich, G. de Couto et al., "Cardiospheres reverse adverse remodeling in chronic rat myocardial infarction: roles of soluble endoglin and Tgf-? signaling," Basic Research in Cardiology, vol. 109, no. 6, p. 443, 2014.
106. K. Yee, K. Malliaras, H. Kanazawa et al., "Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy," PLoS One, vol. 9, no. 12, article e113805, 2014.
107. J. Ye, A. Boyle, H. Shih et al., "Sca-1+ cardiosphere-derived cells are enriched for isl1-expressing cardiac precursors and improve cardiac function after myocardial injury," PLoS One, vol. 7, no. 1, article e30329, 2012.
108. R. R. Makkar, R. R. Smith, K. Cheng et al., "Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial," Lancet (London, England), vol. 379, no. 9819, pp. 895-904, 2012.
109. K. Malliaras, R. R. Makkar, R. R. Smith et al., "Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-derived aUtologous stem CElls to reverse ventricular dysfunction)," Journal of the American College of Cardiology, vol. 63, no. 2, pp. 110-122, 2014.
110. T. Chakravarty, R. R. Makkar, D. D. Ascheim et al., "ALLogeneic heart STem cells to achieve myocardial regeneration (ALLSTAR) trial: rationale and design," Cell Transplantation, vol. 26, no. 2, pp. 205-214, 2017.
111. C. Bearzi, A. Leri, F. Lo Monaco et al., "Identification of a coronary vascular progenitor cell in the human heart," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15885-15890, 2009.
112. H. Kubo, N. Jaleel, A. Kumarapeli et al., "Increased cardiac myocyte progenitors in failing human hearts," Circulation, vol. 118, no. 6, pp. 649-657, 2008.
113. K. C. Flanders, M. G. Holder, and T. S. Winokur, "Autoinduction of mRNA and protein expression for transforming growth factor-beta S in cultured cardiac cells," Journal of Molecular and Cellular Cardiology, vol. 27, no. 2, pp. 805-812, 1995.
114. A. Behfar, L. V. Zingman, D. M. Hodgson et al., "Stem cell differentiation requires a paracrine pathway in the heart," The FASEB Journal, vol. 16, no. 12, pp. 1558-1566, 2002.
115. A. Deb, "Cell-cell interaction in the heart via Wnt/?-catenin pathway after cardiac injury," Cardiovascular Research, vol. 102, no. 2, pp. 214-223, 2014.
116. T. Hosoda, H. Zheng, M. Cabral-Da-Silva et al., "Human cardiac stem cell differentiation is regulated by a mircrine mechanism," Circulation, vol. 123, no. 12, pp. 1287-1296, 2011.
117. A. Gonzalez, M. Rota, D. Nurzynska et al., "Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan," Circulation Research, vol. 102, no. 5, pp. 597-606, 2008.
118. A. M. Samarel, "Costameres, focal adhesions, and cardiomyocyte mechanotransduction," American Journal of Physiology Heart and Circulatory Physiology, vol. 289, no. 6, pp. H2291-H2301, 2005.
119. F. A. High, M. M. Lu, W. S. Pear, K. M. Loomes, K. H. Kaestner, and J. A. Epstein, "Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development," Proceedings of the National Academy of Sciences, vol. 105, no. 6, pp. 1955-1959, 2008.
120. N. Gude, E. Joyo, H. Toko et al., "Notch activation enhances lineage commitment and protective signaling in cardiac progenitor cells," Basic Research in Cardiology, vol. 110, no. 3, p. 29, 2015.
121. C. Urbich, A. Aicher, C. Heeschen et al., "Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells," Journal of Molecular and Cellular Cardiology, vol. 39, no. 5, pp. 733-742, 2005.
122. I. Zlatanova, C. Pinto, and J.-S. Silvestre, "Immune modulation of cardiac repair and regeneration: the art of mending broken hearts," Frontiers in Cardiovascular Medicine, vol. 3, p. 40, 2016.
123. L. Raffaghello, G. Bianchi, M. Bertolotto et al., "Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche," Stem Cells, vol. 26, no. 1, pp. 151-162, 2008.
124. S. Aggarwal and M. F. Pittenger, "Human mesenchymal stem cells modulate allogeneic immune cell responses," Blood, vol. 105, no. 4, pp. 1815-1822, 2005.
125. M. Di Nicola, C. Carlo-Stella, M. Magni et al., "Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli," Blood, vol. 99, no. 10, pp. 3838-3843, 2002.
126. F. van den Akker, J. C. Deddens, P. A. Doevendans, and J. P. G. Sluijter, "Cardiac stem cell therapy to modulate inflammation upon myocardial infarction," Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1830, no. 2, pp. 2449-2458, 2013.
127. K. Fujiu, J. Wang, and R. Nagai, "Cardioprotective function of cardiac macrophages," Cardiovascular Research, vol. 102, no. 2, pp. 232-239, 2014.
128. P. C. H. Hsieh, M. E. Davis, J. Gannon, C. MacGillivray, and R. T. Lee, "Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers," The Journal of Clinical Investigation, vol. 116, no. 1, pp. 237-248, 2006.
129. K. M. Vannella and T. A. Wynn, "Mechanisms of organ injury and repair by macrophages," Annual Review of Physiology, vol. 79, no. 1, pp. 593-617, 2017.
130. G. de Couto, W. Liu, E. Tseliou et al., "Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction," The Journal of Clinical Investigation, vol. 125, no. 8, pp. 3147-3162, 2015.
131. K. S. Campbell and J. Hasegawa, "Natural killer cell biology: an update and future directions," The Journal of Allergy and Clinical Immunology, vol. 132, no. 3, pp. 536-544, 2013.
132. W. Boukouaci, L. Lauden, J. Siewiera et al., "Natural killer cell crosstalk with allogeneic human cardiac-derived stem/progenitor cells controls persistence," Cardiovascular Research, vol. 104, no. 2, pp. 290-302, 2014.
133. Y. Zhou, P. Pan, L. Yao et al., "CD117-positive cells of the heart: progenitor cells or mast cells?," The Journal of Histochemistry and Cytochemistry, vol. 58, no. 4, pp. 309-316, 2010.
134. N. Takeda and I. Manabe, "Cellular interplay between cardiomyocytes and nonmyocytes in cardiac remodeling," International Journal of Inflammation, vol. 2011, Article ID 535241, 13 pages, 2011.
135. P. Balakumar, A. P. Singh, S. S. Ganti, P. Krishan, S. Ramasamy, and M. Singh, "Resident cardiac mast cells: are they the major culprit in the pathogenesis of cardiac hypertrophy?," Basic & Clinical Pharmacology & Toxicology, vol. 102, no. 1, pp. 5-9, 2008.
136. X. Zhang, M.-R. Shen, Z.-D. Xu et al., "Cardiomyocyte differentiation induced in cardiac progenitor cells by cardiac fibroblast-conditioned medium," Experimental Biology and Medicine (Maywood, N.J.), vol. 239, no. 5, pp. 628-637, 2014.
137. T. Moore-Morris, N. Guimaraes-Camboa, I. Banerjee et al., "Resident fibroblast lineages mediate pressure overloadinduced cardiac fibrosis," The Journal of Clinical Investigation, vol. 124, no. 7, pp. 2921-2934, 2014.
138. B. Zhou, L. B. Honor, H. He et al., "Adult mouse epicardium modulates myocardial injury by secreting paracrine factors," The Journal of Clinical Investigation, vol. 121, no. 5, pp. 1894-1904, 2011.
139. F. Limana, C. Bertolami, A. Mangoni et al., "Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid," Journal of Molecular and Cellular Cardiology, vol. 48, no. 4, pp. 609-618, 2010.
140. A. C. Gittenberger-de Groot, E. M. Winter, and R. E. Poelmann, "Epicardium-derived cells (EPDCs) in development, cardiac disease and repair of ischemia," Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1056-1060, 2010.
141. A. Lepilina, A. N. Coon, K. Kikuchi et al., "A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration," Cell, vol. 127, no. 3, pp. 607-619, 2006.
142. H. Lie-Venema, N. M. S. van den Akker, N. A. M. Bax et al., "Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development," Scientific World Journal, vol. 7, pp. 1777-1798, 2007.
143. A. Wessels and J. M. Perez-Pomares, "The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells," The Anatomical Record Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, vol. 276, no. 1, pp. 43-57, 2004.
144. S. Bollini, N. Smart, and P. R. Riley, "Resident cardiac progenitor cells: at the heart of regeneration," Journal of Molecular and Cellular Cardiology, vol. 50, no. 2, pp. 296-303, 2011.
145. T. H. P. Chen, T.-C. Chang, J.-O. Kang et al., "Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic fact," Developmental Biology, vol. 250, no. 1, pp. 198-207, 2002.
146. E. M. Winter, A. A. M. Van Oorschot, B. Hogers et al., "A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells," Circulation Heart Failure, vol. 2, no. 6, pp. 643-653, 2009.
147. L. M. Popescu and M.-S. Faussone-Pellegrini, "Telocytes-a case of serendipity: the winding way from interstitial cells of Cajal (ICC), via interstitial Cajal-like cells (ICLC) to telocytes," Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 729-740, 2010.
148. M. Gherghiceanu and L. M. Popescu, "Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images," Journal of Cellular and Molecular Medicine, vol. 14, no. 4, pp. 871-877, 2010.
149. L. M. Popescu, E. T. Fertig, and M. Gherghiceanu, "Reaching out: junctions between cardiac telocytes and cardiac stem cells in culture," Journal of Cellular and Molecular Medicine, vol. 20, no. 2, pp. 370-380, 2016.
150. Y. Bei, F. Wang, C. Yang, and J. Xiao, "Telocytes in regenerative medicine," Journal of Cellular and Molecular Medicine, vol. 19, no. 7, pp. 1441-1454, 2015.
151. D. Bani, L. Formigli, M. Gherghiceanu, and M. S. Faussone-Pellegrini, "Telocytes as supporting cells for myocardial tissue organization in developing and adult heart," Journal of Cellular and Molecular Medicine, vol. 14, no. 10, pp. 2531-2538, 2010.
152. C. G. Manole, V. Cismasiu, M. Gherghiceanu, and L. M. Popescu, "Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis," Journal of Cellular and Molecular Medicine, vol. 15, no. 11, pp. 2284-2296, 2011.
153. V. B. Cismasiu, E. Radu, and L. M. Popescu, "miR-193 expression differentiates telocytes from other stromal cells," Journal of Cellular and Molecular Medicine, vol. 15, no. 5, pp. 1071-1074, 2011.
154. G. Luxán, G. D'Amato, D. MacGrogan, and J. L. de la Pompa, "Endocardial notch signaling in cardiac development and disease," Circulation Research, vol. 118, no. 1, pp. e1-e18, 2016.
155. K. Niessen and A. Karsan, "Notch signaling in cardiac development," Circulation Research, vol. 102, no. 10, pp. 1169-1181, 2008.
156. J. L. De la Pompa and J. A. Epstein, "Coordinating tissue interactions: notch signaling in cardiac development and disease," Developmental Cell, vol. 22, no. 2, pp. 244-254, 2012.
157. A. Boni, K. Urbanek, A. Nascimbene et al., "Notch1 regulates the fate of cardiac progenitor cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 40, pp. 15529-15534, 2008.
158. C. Kwon, L. Qian, P. Cheng, V. Nigam, J. Arnold, and D. Srivastava, "A regulatory pathway involving Notch1/ beta-catenin/Isl1 determines cardiac progenitor cell fate," Nature Cell Biology, vol. 11, no. 8, pp. 951-957, 2009.
159. N. Gude and M. Sussman, "Notch signaling and cardiac repair," Journal of Molecular and Cellular Cardiology, vol. 52, no. 6, pp. 1226-1232, 2012.
160. C. Collesi, L. Zentilin, G. Sinagra, and M. Giacca, "Notch1 signaling stimulates proliferation of immature cardiomyocytes," The Journal of Cell Biology, vol. 183, no. 1, pp. 117-128, 2008.
161. E. Øie, W. J. Sandberg, M. S. Ahmed et al., "Activation of notch signaling in cardiomyocytes during post-infarction remodeling," Scandinavian Cardiovascular Journal, vol. 44, no. 6, pp. 359-366, 2010.
162. N. A. Gude, G. Emmanuel, W. Wu et al., "Activation of notch-mediated protective signaling in the myocardium," Circulation Research, vol. 102, no. 9, pp. 1025-1035, 2008.
163. P. Kratsios, C. Catela, E. Salimova et al., "Distinct roles for cell-autonomous notch signaling in cardiomyocytes of the embryonic and adult heart," Circulation Research, vol. 106, no. 3, pp. 559-572, 2010.
164. B. Yu and B. Song, "Notch 1 signalling inhibits cardiomyocyte apoptosis in ischaemic postconditioning," Heart, Lung and Circulation, vol. 23, no. 2, pp. 152-158, 2014.
165. P. Rizzo, D. Mele, C. Caliceti et al., "The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors," Frontiers in Oncology, vol. 4, p. 384, 2014.
166. M. Mazzone, L. M. Selfors, J. Albeck et al., "Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 11, pp. 5012-5017, 2010.
167. M. Guentchev and R. D. G. McKay, "Notch controls proliferation and differentiation of stem cells in a dose-dependent manner," The European Journal of Neuroscience, vol. 23, no. 9, pp. 2289-2296, 2006.
168. A. V. Boopathy, P. L. Che, I. Somasuntharam et al., "The modulation of cardiac progenitor cell function by hydrogeldependent Notch1 activation," Biomaterials, vol. 35, no. 28, pp. 8103-8112, 2014.
169. J. Günter, P. Wolint, A. Bopp et al., "Microtissues in cardiovascular medicine: regenerative potential based on a 3D microenvironment," Stem Cells International, vol. 2016, Article ID 9098523, 20 pages, 2016.
170. E. Forte, F. Miraldi, I. Chimenti et al., "TGF?-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies," Stem Cells and Development, vol. 21, no. 17, pp. 3081-3090, 2012.
171. M. A. Rossi, "Connective tissue skeleton in the normal left ventricle and in hypertensive left ventricular hypertrophy and chronic chagasic myocarditis," Medical Science Monitor, vol. 7, pp. 820-832, 2001.
172. C. Jourdan-Lesaux, J. Zhang, and M. L. Lindsey, "Extracellular matrix roles during cardiac repair," Life Sciences, vol. 87, pp. 391-400, 2010.
173. Y. Matsui, J. Morimoto, and T. Uede, "Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction," World Journal of Biological Chemistry, vol. 1, no. 5, pp. 69-80, 2010.
174. B. I. Jugdutt, "Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?," Circulation, vol. 108, no. 11, pp. 1395-1403, 2003.
175. K. V. T. Engebretsen, A. Waehre, J. L. Bjørnstad et al., "Decorin, lumican, and their GAG chain-synthesizing enzymes are regulated in myocardial remodeling and reverse remodeling in the mouse," Journal of Applied Physiology, vol. 114, no. 8, pp. 988-997, 2013.
176. K. Imanaka-Yoshida, "Tenascin-C in cardiovascular tissue remodeling," Circulation Journal, vol. 76, no. 11, pp. 2513-2520, 2012.
177. G. R. Martin and R. Timpl, "Laminin and other basement membrane components," Annual Review of Cell Biology, vol. 3, pp. 57-85, 1987.
178. S. Corda, J. L. Samuel, and L. Rappaport, "Extracellular matrix and growth factors during heart growth," Heart Failure Reviews, vol. 5, no. 2, pp. 119-130, 2000.
179. P. Carmeliet and R. K. Jain, "Molecular mechanisms and clinical applications of angiogenesis," Nature, vol. 473, no. 7347, pp. 298-307, 2011.
180. D. I. Bromage, S. M. Davidson, and D. M. Yellon, "Stromal derived factor 1?: a chemokine that delivers a two-pronged defence of the myocardium," Pharmacology & Therapeutics, vol. 143, no. 3, pp. 305-315, 2014.
181. K. E. Porter and N. A. Turner, "Cardiac fibroblasts: at the heart of myocardial remodeling," Pharmacology & Therapeutics, vol. 123, pp. 255-278, 2009.
182. S. Israeli-Rosenberg, A. M. Manso, H. Okada, and R. S. Ross, "Integrins and integrin-associated proteins in the cardiac myocyte," Circulation Research, vol. 114, no. 3, pp. 572-586, 2014.
183. N. J. Merna, K. M. Fung, J. J. Wang et al., "Differential ?3 integrin expression regulates the response of human lung and cardiac fibroblasts to extracellular matrix and its components," Tissue Engineering Part A, vol. 21, pp. 1-11, 2015.
184. A. Mauretti, N. A. M. Bax, M. H. van Marion, M. J. Goumans, C. Sahlgren, and C. V. C. Bouten, "Cardiomyocyte progenitor cell mechanoresponse unrevealed: strain avoidance and mechanosome development," Integrative Biology, vol. 8, no. 9, pp. 991-1001, 2016.
185. B. D. Cosgrove, K. L. Mui, T. P. Driscoll et al., "Role of extracellular matrix signaling cues in modulating cell fate commitment for cardiovascular tissue engineering," Advanced Healthcare Materials, vol. 3, no. 5, pp. 628-641, 2016.
186. K. M. French, A. V. Boopathy, J. A. Dequach et al., "A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro," Acta Biomaterialia, vol. 8, no. 12, pp. 4357-4364, 2012.
187. R. Gaetani, C. Yin, N. Srikumar et al., "Cardiac derived extracellular matrix enhances cardiogenic properties of human cardiac progenitor cells," Cell Transplantation, vol. 25, no. 858, pp. 1653-1663, 2015.
188. K. M. French, J. T. Maxwell, S. Bhutani et al., "Fibronectin and cyclic strain improve cardiac progenitor cell regenerative potential in vitro," Stem Cells International, vol. 2016, Article ID 8364382, 11 pages, 2016.
189. M. H. Konstandin, H. Toko, G. M. Gastelum et al., "Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction," Circulation Research, vol. 113, no. 2, pp. 115-125, 2013.
190. C. Williams, E. Budina, W. L. Stoppel et al., "Cardiac extracellular matrix-fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineering," Acta Biomaterialia, vol. 14, pp. 84-95, 2015.
191. M. Tallawi, R. Rai, A. R. Boccaccini, and K. Aifantis, "Effect of substrate mechanics on cardiomyocyte maturation and growth," Tissue Engineering Part B, Reviews, vol. 21, no. 1, pp. 157-165, 2014.
192. J. L. Young and A. J. Engler, "Hydrogels with time-dependent material properties enhance cardiomyocyte differentiation in vitro," Biomaterials, vol. 32, no. 4, pp. 1002-1009, 2011.
193. M. Y. Choi, J. T. Kim, W. J. Lee et al., "Engineered extracellular microenvironment with a tunable mechanical property for controlling cell behavior and cardiomyogenic fate of cardiac stem cells," Acta Biomaterialia, vol. 50, pp. 234-248, 2017.
194. J. A. Hannafin, E. A. Attia, R. Henshaw, R. F. Warren, and M. M. Bhargava, "Effect of cyclic strain and plating matrix on cell proliferation and integrin expression by ligament fibroblasts," Journal of Orthopaedic Research, vol. 24, no. 2, pp. 149-158, 2006.
195. H. E. Balcioglu, H. van Hoorn, D. M. Donato, T. Schmidt, and E. H. J. Danen, "The integrin expression profile modulates orientation and dynamics of force transmission at cellmatrix adhesions," Journal of Cell Science, vol. 128, no. 7, pp. 1316-1326, 2015.
196. M. H. van Marion, N. A. M. Bax, M. C. van Turnhout et al., "Behavior of CMPCs in unidirectional constrained and stress-free 3D hydrogels," Journal of Molecular and Cellular Cardiology, vol. 87, pp. 79-91, 2015.
197. A. Mohyeldin, T. Garzón-Muvdi, and A. Quiñones-Hinojosa, "Oxygen in stem cell biology: a critical component of the stem cell niche," Cell Stem Cell, vol. 7, no. 2, pp. 150-161, 2010.
198. B. Keith and M. C. Simon, "Hypoxia-inducible factors, stem cells, and cancer," Cell, vol. 129, no. 3, pp. 465-472, 2007.
199. M. V. Gustafsson, X. Zheng, T. Pereira et al., "Hypoxia requires Notch signaling to maintain the undifferentiated cell state," Developmental Cell, vol. 9, no. 5, pp. 617-628, 2005.
200. J. M. Adams, L. T. Difazio, R. H. Rolandelli et al., "HIF-1: a key mediator in hypoxia," Acta Physiologica Hungarica, vol. 96, no. 1, pp. 19-28, 2009.
201. J. S. Jurgensen, C. Rosenberger, M. S. Wiesener et al., "Persistent induction of HIF-1alpha and-2alpha in cardiomyocytes and stromal cells of ischemic myocardium," The FASEB Journal, vol. 18, no. 12, pp. 1415-1417, 2004.
202. D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan et al., "Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1," Nature Medicine, vol. 10, no. 8, pp. 858-864, 2004.
203. P. Staller, J. Sulitkova, J. Lisztwan, H. Moch, E. J. Oakeley, and W. Krek, "Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL," Nature, vol. 425, no. 6955, pp. 307-311, 2003.
204. A. Zernecke, A. Schober, I. Bot et al., "SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells," Circulation Research, vol. 96, no. 7, pp. 784-791, 2005.
205. K. Jujo, H. Hamada, A. Iwakura et al., "CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 24, pp. 11008-11013, 2010.
206. H. Zheng, G. Fu, T. Dai, and H. Huang, "Migration of endothelial progenitor cells mediated by stromal cellderived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway," Journal of Cardiovascular Pharmacology, vol. 50, no. 3, pp. 274-280, 2007.
207. S. K. Ghadge, S. Muhlstedt, C. Ozcelik, and M. Bader, "SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction," Pharmacology & Therapeutics, vol. 129, no. 1, pp. 97-108, 2011.
208. N. Smart and P. R. Riley, "The stem cell movement," Circulation Research, vol. 102, no. 10, pp. 1155-1168, 2008.
209. Y. L. Tang, W. Zhu, M. Cheng et al., "Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression," Circulation Research, vol. 104, no. 10, pp. 1209-1216, 2009.
210. D. Chen, Y. Xia, K. Zuo et al., "Crosstalk between SDF-1/ CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration," Scientific Reports, vol. 5, article 16813, 2015.
211. A. A. M. van Oorschot, A. M. Smits, E. Pardali, P. A. Doevendans, and M.-J. Goumans, "Low oxygen tension positively influences cardiomyocyte progenitor cell function," Journal of Cellular and Molecular Medicine, vol. 15, no. 12, pp. 2723-2734, 2011.
212. D. J. Ceradini and G. C. Gurtner, "Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue," Trends in Cardiovascular Medicine, vol. 15, no. 2, pp. 57-63, 2005.
213. T.-M. Achilli, J. Meyer, and J. R. Morgan, "Advances in the formation, use and understanding of multi-cellular spheroids," Expert Opinion on Biological Therapy, vol. 12, no. 10, pp. 1347-1360, 2012.
214. Y. Li, Y. Hiroi, and J. K. Liao, "Notch signaling as an important mediator of cardiac repair and regeneration after myocardial infarction," Trends in Cardiovascular Medicine, vol. 20, no. 7, pp. 228-231, 2010.
215. F. Gattazzo, A. Urciuolo, and P. Bonaldo, "Extracellular matrix: a dynamic microenvironment for stem cell niche," Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1840, no. 8, pp. 2506-2519, 2014.
216. E. Cambria, J. Steiger, J. Günter et al., "Cardiac regenerative medicine: the potential of a new generation of stem cells," Transfusion Medicine and Hemotherapy, vol. 43, no. 4, pp. 275-281, 2016.
217. S. Pok, J. D. Myers, S. V. Madihally, and J. G. Jacot, "A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering," Acta Biomaterialia, vol. 9, no. 3, pp. 5630-5642, 2013.
218. T. D. Johnson, J. A. Dequach, R. Gaetani et al., "Human versus porcine tissue sourcing for an injectable myocardial matrix hydrogel," Biomaterials Science, vol. 2014, article 60283D, 2014.
219. R. Gaetani, P. A. Doevendans, C. H. Metz et al., "Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells," Biomaterials, vol. 33, no. 6, pp. 1782-1790, 2012.
220. T. C. K. Liu, S. Ismail, O. Brennan, C. Hastings, and G. P. Duffy, "Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin-mediated toxicity," Journal of Tissue Engineering and Regenerative Medicine, vol. 7, no. 4, pp. 302-311, 2013.
221. J. Leor, Y. Amsalem, and S. Cohen, "Cells, scaffolds, and molecules for myocardial tissue engineering," Pharmacology & Therapeutics, vol. 105, no. 2, pp. 151-163, 2005.
222. K. Cheng, D. Shen, J. Smith et al., "Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction," Biomaterials, vol. 33, no. 10, pp. 2872-2879, 2012.
223. M. Tiburcy, J. E. Hudson, P. Balfanz et al., "Defined engineered human myocardium with advanced maturation for applications in heart failure modelling and repair," Circulation, vol. 135, no. 19, pp. 1832-1847, 2017.
224. S. S. Nunes, J. W. Miklas, J. Liu et al., "Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes," Nature Methods, vol. 10, no. 8, pp. 781-787, 2013.
225. N. L. Tulloch, V. Muskheli, M. V. Razumova et al., "Growth of engineered human myocardium with mechanical loading and vascular coculture," Circulation Research, vol. 109, no. 1, pp. 47-59, 2011.
226. D. Zhang, I. Y. Shadrin, J. Lam, H. Q. Xian, H. R. Snodgrass, and N. Bursac, "Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes," Biomaterials, vol. 34, no. 23, pp. 5813-5820, 2013.
227. E. Ghafar-Zadeh, J. R. Waldeisen, and L. P. Lee, "Engineered approaches to the stem cell microenvironment for cardiac tissue regeneration," Lab on a Chip, vol. 11, no. 18, pp. 3031-3048, 2011.
228. D. E. Discher, D. J. Mooney, and P. W. Zandstra, "Growth factors, matrices, and forces combine and control stem cells," Science, vol. 324, no. 5935, pp. 1673-1677, 2009.
229. D. E. Discher, P. Janmey, and Y.-L. Wang, "Tissue cells feel and respond to the stiffness of their substrate," Science, vol. 310, no. 5751, pp. 1139-1143, 2005.
230. A. M. Throm Quinlan, L. N. Sierad, A. K. Capulli, L. E. Firstenberg, and K. L. Billiar, "Combining dynamic stretch and tunable stiffness to probe cell mechanobiology in vitro," PLoS One, vol. 6, no. 8, article e23272, 2011.
231. N. Tandon, C. Cannizzaro, P.-H. G. Chao et al., "Electrical stimulation systems for cardiac tissue engineering," Nature Protocols, vol. 4, no. 2, pp. 155-173, 2009.
232. B. Murtuza, J. W. Nichol, and A. Khademhosseini, "Microand nanoscale control of the cardiac stem cell niche for tissue fabrication," Tissue Engineering Part B, vol. 15, no. 4, pp. 443-454, 2009.
233. C. Morez, M. Noseda, M. A. Paiva, E. Belian, M. D. Schneider, and M. M. Stevens, "Enhanced efficiency of genetic programming toward cardiomyocyte creation through topographical cues," Biomaterials, vol. 70, pp. 94-104, 2015.